• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Can J Cardiol . Influenza vaccination in congenital heart disease in the pre-COVID19 era: Coverage rate, patient characteristics and outcome

tetano

Editor, Senior Moderator
Can J Cardiol


. 2021 May 4;S0828-282X(21)00216-6.
doi: 10.1016/j.cjca.2021.04.010. Online ahead of print.
Influenza vaccination in congenital heart disease in the pre-COVID19 era: Coverage rate, patient characteristics and outcome


Philip Moons[SUP] 1 [/SUP], Steffen Fieuws[SUP] 2 [/SUP], Corinne Vandermeulen[SUP] 2 [/SUP], Fouke Ombelet[SUP] 3 [/SUP], Ruben Willems[SUP] 4 [/SUP], Eva Goossens[SUP] 5 [/SUP], Liesbet Van Bulck[SUP] 6 [/SUP], Mich?le de Hosson[SUP] 7 [/SUP], Lieven Annemans[SUP] 4 [/SUP], Werner Budts[SUP] 8 [/SUP], Julie De Backer[SUP] 7 [/SUP], St?phane Moniotte[SUP] 9 [/SUP], Arianne Marelli[SUP] 10 [/SUP], Katya De Groote[SUP] 11 [/SUP], BELCODAC consortium



Affiliations
Free article

Abstract

Background: Influenza vaccination is the most commonly recommended immune prevention strategy. However, data on influenza vaccination in patients with congenital heart disease (CHD) is scarce. In this study, our goals were to (i) measure vaccination coverage rates (VCR) for influenza in a large cohort of children, adolescents and adults with CHD, (ii) identity patient characteristics as predictors for vaccination, and (iii) investigate the impact of influenza vaccination on hospitalization.
Methods: A nationwide cohort study in Belgium included 16,778 patients, representing 134,782 vaccination years, from the BELgian COngenital heart disease Database combining Administrative and Clinical data (BELCODAC). Data over 9 vaccination years (2006-2015) were used, and patients were stratified into five age cohorts: 6 months-4 years; 5-17 years; 18-49 years; 50-64 years; and ?65 years.
Results: In the respective age cohorts, the VCR was estimated to be 6.6%, 8.0%, 23.9%, 46.6%, and 72.8%. There was a steep increase in VCR as of the age of 40 years. Multivariable logistic regression showed that higher anatomical complexity of CHD, older age, presence of genetic syndromes, and prior cardiac interventions were associated with significantly higher VCRs. Among adults, men had lower and pregnant women had higher VCRs. The association between influenza vaccination and all-cause hospitalization was not significant in this study.
Conclusion: The influenza VCR in people with CHD is low, especially in children and adolescents. Older patients, particularly those with complex CHD, are well covered. Our findings should inform vaccination promotion strategies in populations with CHD.

Keywords: counselling; heart defects, congenital; influenza; prevention; vaccination; vaccination coverage rate.
 
Back
Top Bottom